Skip to content

Clinical trials

Arterial Occlusive Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arterial Occlusive Diseases Clear all

222 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20023
20035
20048
20058
20066
20073
20086
20094
20105
201110
20129
201312
20148
20158
201610
20179
201813
201918
202016
202110
202211
20236
20245
202510
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed130
Unknown status37
Terminated18
Recruiting16
Withdrawn9
Not yet recruiting4
Active, not recruiting4
Suspended2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)9
C. R. Bard5
Beijing Northland Biotech. Co., Ltd.4
Boston Scientific Corporation4
Brigham and Women's Hospital4
Cordis US Corp.4
Medtronic Vascular4
ARCA Biopharma, Inc.3
China National Center for Cardiovascular Diseases3
Fundación EPIC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arterial Occlusive Diseases222
Cardiovascular Diseases67
Coronary Artery Disease66
Vascular Diseases58
Arteriosclerosis47
Coronary Disease47
Myocardial Ischemia43
Heart Diseases42
Peripheral Arterial Disease42
Peripheral Vascular Diseases38

Trials

Showing 26 to 50 of 222. Each trial links to its page on Pharma Observatory.

122 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.